1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Can misfolded proteins be beneficial? The HAMLET case.
(
- Contribution to journal › Scientific review
-
Mark
Changes in proteasome structure and function caused by HAMLET in tumor cells.
(
- Contribution to journal › Article
-
Mark
HAMLET (human alpha-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death.
(
- Contribution to journal › Article
-
Mark
HAMLET, a tumoricidal molecular complex from human milk
2009) 6th International Symposium on the Intraductal Approach to Breast Cancer In BMC Proceedings 3(Suppl 5). p.11-11(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells).
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4.
(
- Contribution to journal › Article
-
Mark
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
(
- Contribution to journal › Article
-
Mark
Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells).
(
- Contribution to journal › Article
- 2006
-
Mark
HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53.
(
- Contribution to journal › Article
-
Mark
Unfolded Protein Overload, Proteasome Activation and Death in HAMLET-Treated Tumor Cells
2006) Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic In IDrugs 9(3). p.29-29(
- Contribution to journal › Published meeting abstract